Detailed information for compound 1825192
Basic information
Technical information
- Name: Unnamed compound
- MW: 406.43 | Formula: C20H26N2O7
-
H donors: 3
H acceptors: 5
LogP: -1.41
Rotable bonds: 6
Rule of 5 violations (Lipinski): 1 - SMILES: OC(=O)/C=C/C(=O)O.COc1cc(OC)ccc1C(=O)N1C[C@@H]2CNC[C@H](C1)C2
- InChi: 1S/C16H22N2O3.C4H4O4/c1-20-13-3-4-14(15(6-13)21-2)16(19)18-9-11-5-12(10-18)8-17-7-11;5-3(6)1-2-4(7)8/h3-4,6,11-12,17H,5,7-10H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t11-,12+;
- InChiKey: VFDUPBOYJMUYBB-HPJNZGNTSA-N
Network
Hover on a compound node to display the structore
Synonyms
No synonyms found for this compound
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Rattus norvegicus | Neuronal acetylcholine receptor; alpha4/beta2 | Starlite/ChEMBL | References |
| Rattus norvegicus | Neuronal acetylcholine receptor protein alpha-7 subunit | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Onchocerca volvulus | 0.0239 | 1 | 1 | |
| Mycobacterium leprae | Conserved hypothetical protein | 0.0239 | 1 | 0.5 |
| Mycobacterium ulcerans | putative transglutaminase-like protein | 0.0239 | 1 | 0.5 |
| Echinococcus granulosus | Transglutaminase | 0.0239 | 1 | 0.5 |
| Mycobacterium leprae | Conserved hypothetical protein | 0.0239 | 1 | 0.5 |
| Mycobacterium ulcerans | hypothetical protein | 0.0239 | 1 | 0.5 |
| Echinococcus multilocularis | Transglutaminase | 0.0239 | 1 | 0.5 |
| Trichomonas vaginalis | peptide N-glycanase, putative | 0.0239 | 1 | 0.5 |
| Mycobacterium ulcerans | transglutaminase family protein | 0.0239 | 1 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.13 | 1 |
| Mycobacterium tuberculosis | Conserved protein | 0.0239 | 1 | 0.5 |
| Mycobacterium tuberculosis | Long conserved protein | 0.0239 | 1 | 0.5 |
| Mycobacterium tuberculosis | Hypothetical protein | 0.0239 | 1 | 0.5 |
| Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0239 | 1 | 0.5 |
| Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0239 | 1 | 0.5 |
| Giardia lamblia | Hypothetical protein | 0.0239 | 1 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.13 | 1 |
| Mycobacterium ulcerans | hypothetical protein | 0.0239 | 1 | 0.5 |
| Giardia lamblia | Transglutaminase/protease, putative | 0.0239 | 1 | 0.5 |
| Schistosoma mansoni | hypothetical protein | 0.0239 | 1 | 1 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| Ki (binding) | > 1000 nM | Displacement of [3H]epibatidine from alpha4beta2 nAChR in Sprague-Dawley rat forebrain P2 fraction after 90 mins by liquid scintillation counting analysis | ChEMBL. | 24156938 |
| Ki (binding) | > 5000 nM | Displacement of [3H]methyllycaconitine from alpha7 nAChR in Sprague-Dawley rat forebrain P2 fraction after 90 mins by liquid scintillation counting analysis | ChEMBL. | 24156938 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL3094091
Bibliographic References
No literature references available for this target.
If you have references for this compound, please enter them in a user comment (below) or Contact us.